6505--Levetiracetam Tablets

The Department of Veterans Affairs National Acquisition Center is seeking to procure Levetiracetam Tablets through solicitation 36E79726R0001. This pharmaceutical contract will supply Levetiracetam in four strengths (250mg, 500mg, 750mg, and 1,000mg) across seven line items in various package sizes (60, 120, and 500 tablets per bottle). The solicitation requires offerors to provide FDA-approved products manufactured in compliance with current Good Manufacturing Practices, with unique NDC numbers assigned to each offering. Proposals must include pricing for all line items and contract years, incorporating a 0.5% Cost Recovery Fee. The original proposal deadline of November 26, 2025, has been extended to December 3, 2025, at 2:30 PM Central Time, and all proposals must be submitted electronically via email to the specified VA contacts.

This procurement is designated as a small business set-aside with a size standard of 1,300 employees, making it restricted to qualifying small business entities. The contract will serve multiple federal agencies including the VA, Department of Defense, Indian Health Service, and Bureau of Prisons, with estimated annual usage ranging from 4,465 to 97,277 bottles per line item depending on the specific strength and package configuration. The contract structure includes a base year followed by four one-year option periods, with a single aggregate award anticipated. While specific contract values are not disclosed in the solicitation notice, the substantial estimated annual usage across multiple federal agencies and the four-year option period indicate a significant procurement. Offerors must include a completed and signed copy of the amendment extending the due date with their proposals.